Methylphenidate for ADHD in Preschoolers
Abstract
The effectiveness of methylphenidate (MPH), 0.3 and 0.5 mg/kg 2x daily, in the treatment of 31 children, aged 4 to 6 years, with attention-deficit hyperactivity disorder (ADHD) was investigated by a double-blind, placebo-controlled study at the University of Ottawa, Canada.
DOI: https://doi.org/10.15844/pedneurbriefs-11-11-2 | Journal eISSN: 2166-6482
Language: English
Page range: 82 - 82
Published on: Nov 1, 1997
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services
© 1997 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.